Kim R. Tsuchimoto, Director at Monopar Therapeutics (MNPR), sold 8,904 shares at $40.00 ($356K) on 2025-07-14, disclosed to the SEC on 2025-07-16.
Seasonal sale ($356k) by Director — this insider has traded MNPR in July in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RPTP | SELL | 2012-08-31 | $18K | — | Filing → |
| RPTP | SELL | 2012-08-29 | $245 | — | Filing → |
| RPTP | SELL | 2012-06-18 | $21K | — | Filing → |